AU2002333235A1 - Pharmaceutical formulation containing an LTB4 antagonist - Google Patents
Pharmaceutical formulation containing an LTB4 antagonistInfo
- Publication number
- AU2002333235A1 AU2002333235A1 AU2002333235A AU2002333235A AU2002333235A1 AU 2002333235 A1 AU2002333235 A1 AU 2002333235A1 AU 2002333235 A AU2002333235 A AU 2002333235A AU 2002333235 A AU2002333235 A AU 2002333235A AU 2002333235 A1 AU2002333235 A1 AU 2002333235A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical formulation
- formulation containing
- ltb4 antagonist
- ltb4
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VNYSSYRCGWBHLG-AMOLWHMGSA-N Leukotriene B4 Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-AMOLWHMGSA-N 0.000 title 1
- 101700059544 PTGR1 Proteins 0.000 title 1
- 230000003042 antagnostic Effects 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10134377.9 | 2001-07-14 | ||
| DE10134377 | 2001-07-14 | ||
| DE10206241A DE10206241A1 (en) | 2001-07-14 | 2002-02-15 | Drug formulation containing an LTB antagonist |
| DE10206241.2 | 2002-02-15 | ||
| PCT/EP2002/007618 WO2003007922A2 (en) | 2001-07-14 | 2002-07-09 | Pharmaceutical formulation containing an ltb4 antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002333235A1 true AU2002333235A1 (en) | 2003-05-22 |
| AU2002333235B2 AU2002333235B2 (en) | 2007-07-12 |
Family
ID=26009704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002333235A Ceased AU2002333235B2 (en) | 2001-07-14 | 2002-07-09 | Pharmaceutical formulation containing an LTB4 antagonist |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1408943B1 (en) |
| JP (1) | JP2005502630A (en) |
| KR (1) | KR100912196B1 (en) |
| CN (1) | CN1298316C (en) |
| AT (1) | ATE298564T1 (en) |
| AU (1) | AU2002333235B2 (en) |
| BR (1) | BR0211090A (en) |
| CA (1) | CA2452357A1 (en) |
| ES (1) | ES2244821T3 (en) |
| HU (1) | HUP0401371A3 (en) |
| IL (1) | IL159493A0 (en) |
| MX (1) | MXPA04000384A (en) |
| NZ (1) | NZ530973A (en) |
| PL (1) | PL368613A1 (en) |
| RU (1) | RU2004102399A (en) |
| UY (1) | UY27376A1 (en) |
| WO (1) | WO2003007922A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10232120A1 (en) | 2002-07-16 | 2004-02-05 | Fev Motorentechnik Gmbh | Method and device for the artificial aging of a motor vehicle catalytic converter |
| RS20050390A (en) * | 2002-11-26 | 2008-04-04 | Boehringer Ingelheim Pharma Gmbh. & Co.Kg., | Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor |
| US20070237823A1 (en) * | 2004-05-04 | 2007-10-11 | Thomas Bock | Solid Pharmaceutical Form Comprising and Ltb4 Antagonist |
| EP3623368A4 (en) | 2017-05-12 | 2021-04-07 | Riken | Class a gpcr-binding compound modifier |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5451700A (en) * | 1991-06-11 | 1995-09-19 | Ciba-Geigy Corporation | Amidino compounds, their manufacture and methods of treatment |
| PT902013E (en) * | 1992-02-05 | 2002-06-28 | Boehringer Ingelheim Pharma | NEW DERIVATIVES AMIDINATE ITS PREPARATION AND USE AS A MEDICINAL PRODUCT WITH ANTAGONIST ACTIVITY OF LTB4 |
| DE4424713A1 (en) * | 1994-07-13 | 1996-01-18 | Boehringer Ingelheim Kg | Substituted benzamidines, their preparation and their use as pharmaceutical substances |
| DE19546452A1 (en) * | 1995-12-13 | 1997-06-19 | Boehringer Ingelheim Kg | New phenylamidine derivatives, process for their preparation and their use as medicaments |
| DE19636689A1 (en) * | 1996-09-10 | 1998-03-12 | Boehringer Ingelheim Kg | New benzamidine derivatives |
| DE19637123A1 (en) * | 1996-09-12 | 1998-03-19 | Boehringer Ingelheim Kg | New pyranoside derivatives |
| DE19948428A1 (en) * | 1999-10-07 | 2001-04-12 | Boehringer Ingelheim Pharma | New LTB¶4¶ antagonist, process for its preparation and its use as a medicament |
-
2002
- 2002-07-09 NZ NZ530973A patent/NZ530973A/en unknown
- 2002-07-09 AU AU2002333235A patent/AU2002333235B2/en not_active Ceased
- 2002-07-09 IL IL15949302A patent/IL159493A0/en unknown
- 2002-07-09 AT AT02787119T patent/ATE298564T1/en not_active IP Right Cessation
- 2002-07-09 JP JP2003513531A patent/JP2005502630A/en active Pending
- 2002-07-09 KR KR1020047000585A patent/KR100912196B1/en not_active IP Right Cessation
- 2002-07-09 MX MXPA04000384A patent/MXPA04000384A/en active IP Right Grant
- 2002-07-09 BR BR0211090-3A patent/BR0211090A/en not_active Expired - Fee Related
- 2002-07-09 ES ES02787119T patent/ES2244821T3/en not_active Expired - Lifetime
- 2002-07-09 RU RU2004102399/15A patent/RU2004102399A/en not_active Application Discontinuation
- 2002-07-09 CN CNB028139763A patent/CN1298316C/en not_active Expired - Fee Related
- 2002-07-09 EP EP02787119A patent/EP1408943B1/en not_active Expired - Lifetime
- 2002-07-09 HU HU0401371A patent/HUP0401371A3/en unknown
- 2002-07-09 WO PCT/EP2002/007618 patent/WO2003007922A2/en active IP Right Grant
- 2002-07-09 CA CA002452357A patent/CA2452357A1/en not_active Abandoned
- 2002-07-09 PL PL02368613A patent/PL368613A1/en not_active Application Discontinuation
- 2002-07-11 UY UY27376A patent/UY27376A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0102342D0 (en) | Pharmaceutical formulation | |
| AU2002321879A1 (en) | Pharmaceutical formulation containing dye | |
| AU2002257582A1 (en) | Pharmaceutical formulation | |
| GB0118689D0 (en) | Pharmaceutical formulation | |
| PL366432A1 (en) | Pharmaceutical formulation | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| AU4328800A (en) | Pharmaceutical formulation | |
| AU2002364468A1 (en) | Solid orally-dispersible pharmaceutical formulation | |
| IL161306A0 (en) | Pharmaceutical formulation comprising (r)-bicalutamide | |
| AU2002333235A1 (en) | Pharmaceutical formulation containing an LTB4 antagonist | |
| AU2003280387A1 (en) | Pharmaceutical formulation comprising azithrocycin monohydrate | |
| AU3839900A (en) | Pharmaceutical formulation | |
| AUPR916301A0 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
| AUPR606401A0 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
| HUP0401371A3 (en) | Pharmaceutical formulation containing an ltb4 antagonist and process for its preparation | |
| AU1388501A (en) | Pharmaceutical formulation | |
| AUPR529701A0 (en) | Pharmaceutical composition | |
| AU2002342940A1 (en) | New pharmaceutical compounds | |
| AU2001274251A1 (en) | Novel pharmaceutical formulation suitable for nebulisation | |
| AU2002238748A1 (en) | Pharmaceutical aerosol formulation | |
| GB0104749D0 (en) | Pharmaceutical formulation | |
| AU2001230490A1 (en) | Pharmaceutical formulation | |
| AU2003238900A1 (en) | Pharmaceutical formulation | |
| AU2002950788A0 (en) | Pharmaceutical formulation | |
| AU2001264145A1 (en) | Novel pharmaceutical formulation suitable for nebulisation |